EXPERIMENTAL STUDY ON THE INHIBITORY EFFECT OF SODIUM CANTHARIDINATE ON HUMAN HEPATOMA HEPG2 CELLS

Authors

  • Shi-Qi Wen
  • Quan Chen
  • Ming Hu

Keywords:

sodium cantharidinate, human hepatoma HepG2, MTT assay

Abstract

Backgroud: Cantharidin, and its derivatives can not only inhibit the proliferation of tumor cells, but can also induce tumor cell apoptosis. It shows cantharidin exhibits a wide range of reactivity in anticancer. The objective of this paper was to study the inhibitory effect of sodium cantharidinate on human hepatoma HepG2 cells. Materials and Methods: MTT assay was used to detect the proliferation of HepG2 cells, and immunohisto-chemical method was used to detect the change in VEGF, protein level, and to determine the inhibitory effect of sodium cantharidinate on human hepatoma HepG2 cells. Results: As results, sodium cantharidinate significantly inhibited the growth of HepG2 cells in a time-and dose-dependent manner. Conclusion: We conclude that sodium cantharidinate has an inhibitory effect on human hepatoma HepG2 cells.

Author Biography

Shi-Qi Wen

Department of Vascular, Gansu Provincial Hospital, Lanzhou 730000, China

Downloads

Published

2013-10-28

How to Cite

Wen, S.-Q., Chen, Q., & Hu, M. (2013). EXPERIMENTAL STUDY ON THE INHIBITORY EFFECT OF SODIUM CANTHARIDINATE ON HUMAN HEPATOMA HEPG2 CELLS. African Journal of Traditional, Complementary and Alternative Medicines, 11(1), 131–134. Retrieved from https://athmsi.org/journals/index.php/ajtcam/article/view/2207

Issue

Vol. 11 No. 1 (2014)

Section

Short communications

License

Copyright: Creative Commons Attribution CC.

This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.